Related Experiment Video
Updated: May 18, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity
Lotten Darlin1, Christer Borgfeldt, Ola Forslund
1Department of Obstetrics and Gynaecology, Skane University Hospital, Lund University, Sweden. Lotten.Darlin@med.lu.se
Summary
A new vaginal self-sampling method effectively detects high-risk human papillomavirus (HPV) infections, similar to clinician-collected samples. This cost-effective approach enhances cervical cancer screening accessibility for women.
Area of Science:
- Gynecology
- Oncology
- Virology
Background:
- Cervical cancer screening programs aim to reach all women, but coverage can be limited.
- Self-sampling (SS) for HPV testing increases screening participation but often relies on expensive commercial kits.
- Alternative, cost-effective methods for HPV detection are needed.
Purpose of the Study:
- To evaluate the adequacy of vaginal self-sampling (SS) for HPV testing without commercial preservatives.
- To compare the performance of vaginal SS HPV testing with traditional clinician-collected samples.
Main Methods:
- Women with abnormal cervical smears were invited to a colposcopy clinic.
- Participants performed vaginal SS using a cotton swab, which was then placed in a sterile cryotube.
- Gynecologists collected liquid-based cytology (LBC) samples, and both were analyzed for high-risk HPV (hr-HPV) using PCR and luminex-based typing.
Main Results:
- High-risk HPV DNA was detected in 60% of SS samples and 59% of LBC samples.
- The agreement between SS and LBC for HPV detection was good (kappa = 0.67).
- Sensitivity for detecting high-grade squamous intraepithelial lesions (HSIL) was comparable between SS (77%) and LBC (79%).
Conclusions:
- Vaginal self-sampling without preservatives demonstrates similar sensitivity to clinician-collected cervical smears for detecting high-risk HPV infections.
- This novel self-sampling method is cost-effective, well-tolerated, and suitable for mail transport, potentially improving cervical cancer screening coverage.
